PLx Pharma was incorporated in Delaware on July 27, 2015.
PLx Pharma’s fiscal year is from January 1 to December 31.
PLx Pharma’s stock is traded as common stock on the NASDAQ Capital Markets under the ticker symbol “PLXP.”
The transfer agent and registrar for shares of PLx Pharma’s common stock is VStock Transfer, LLC.
No, PLx Pharma does not have a direct stock purchase plan.
You’ll find the latest SEC Filings within this link.
Please contact PLx Pharma’s investor relations department with any investor inquiries.
Janet M. Barth Vice President, Investor Relations & Corporate Communications
Phone: (908) 613-5820
Lisa M. Wilson, In-Site Communications, Inc.
You can receive email updates by signing up to be included on the PLx Pharma’s distribution list.